logo
  

Air Liquide, Toyota, CaetanoBus Sign MoU To Develop Hydrogen Mobility In Europe

French industrial gases company Air Liquide Group (AIQUY.PK) announced Tuesday its agreement with Toyota Motor Europe, affiliated to Japanese automajor Toyota Motor Corp. (TYT.L,TM), and Portuguese bus manufacturer CaetanoBus to develop integrated hydrogen solutions in Europe.

The companies have signed a Memorandum of Understanding or MoU for the partnership, which will include infrastructure development and vehicle fleets, to accelerate the expansion of hydrogen mobility for both light and heavy-duty vehicles.

Initial focus will be on buses, light commercial vehicles and cars, with the further aim to accelerate the heavy-duty truck segment.

The deal reflects the partners' ambition to contribute to decarbonizing transport and accelerate the development of local hydrogen ecosystems for multiple mobility applications.

The companies will address the entire value chain of hydrogen mobility, from renewable or low-carbon hydrogen production, distribution and refueling infrastructure to the deployment of different vehicle segments.

They will offer the infrastructure and refueling stations, as well as integrated vehicle offers (leasing and service) to customers such as taxi companies, fleet operators, local authorities, and others.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT